Infectious Disease Control

Legatum Seeds Ebola Crisis Fund With $150,000 Gift

DUBAI, UAE, September 4, 2014 /PRNewswire/ -- The Legatum Foundation, the development arm of the Legatum Group, today announced a donation of$150,000 to the Ebola Crisis Fund, a fund established to help prevent the spread of the deadly Ebola virus inWest Africa. The current outbreak of Ebola, c...

2014-09-04 00:55 2408

ViiV Healthcare receives FDA approval for Triumeq® (abacavir, dolutegravir and lamivudine), a new single-pill regimen for the treatment of HIV-1 infection

LONDON, Aug. 23, 2014 /PRNewswire/ -- ViiV Healthcare announced today that the US Food and Drug Administration (FDA) has approved Triumeq® (abacavir 600mg, dolutegravir 50mg and lamivudine 300mg) tablets for the treatment of HIV-1 infection.1 Triumeq is ViiV Healthcare's first dolutegravir-based ...

2014-08-23 04:17 3899

New Life Sciences Research Reveals Early Stage Treatments to Help Scientists in the Fight against Ebola

PHILADELPHIA, Aug. 18, 2014 /PRNewswire/ -- The Intellectual Property and Science business of Thomson Reuters , the world leader in intelligent information for businesses and professionals, released a comprehensivedisease profile on Ebola Virus Disease

2014-08-18 21:18 2664

A Shot of Good Health : CRY India's Immunization Campaign

SINGAPORE, July 30, 2014 /PRNewswire/ -- Gopika was born against all the odds in an area ofIndia where foeticide is prevalent. Hailing from Ponamalai Nagar, a village in the Salem district of Andhra Pradesh, her family cherished their daughter, taking the utmost care in her health and development...

2014-07-30 20:37 1553

Outlook for Hepatitis Patients Set to Improve with Development of Accessible Treatments

PHILADELPHIA, July 28, 2014 /PRNewswire/ -- The Intellectual Property and Science Business of Thomson Reuters , the world's leading source of intelligent information for businesses and professionals, today released a new study in recognition of World Hepatit...

2014-07-28 21:09 1621

Sinovac to Host Conference Call to Report Second Quarter 2014 Unaudited Financial Results

BEIJING, July 25, 2014 /PRNewswire/ -- Sinovac Biotech Ltd. (Nasdaq: SVA), a leading provider of biopharmaceutical products in China, today announced that it will release its unaudited financial results for the second quarter ended June 30, 2014, after market close on Thursday, August 14, 2014 EDT. ...

2014-07-25 17:00 1480

Founding of WAIDID, the World Association for Infectious Diseases and Immunological Disorders Unveiled at the Infectious Diseases World Summit Shanghai 5-6 July 2014

MILAN, July 7, 2014 /PRNewswire/ -- WAIDID, the new International Scientific Society  presided over by Prof. Susanna Esposito, has the objective of promoting scientific research and the dissemination of information on infectious and immunological diseases on both the national and international ...

2014-07-07 17:55 1821

International Vaccine Institute Launches New Video Marketing Campaign, "Choose Your World"

SEOUL, South Korea, July 2, 2014 /PRNewswire/ -- The International Vaccine Institute (IVI) unveiled today a new integrated video marketing campaign, "Choose Your World," promoting awareness and encouraging grassroots fundraising to support the organization's initiatives. The campaign features a 3-mi...

2014-07-02 12:37 3360

BD Launches New Point-of-Care System for HIV/AIDS Patients

-- Easy-to-use CD4 analysis platform tailored to meet the needs of resource-limited settings SAN JOSE, Calif., May 6, 2014 /PRNewswire/ -- BD Biosciences, a segment of BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced the launch of the BD...

2014-05-06 09:00 1162

FDA Approves Ibalizumab Manufactured by WuXi PharmaTech for Treatment of Patients on Expanded Access

SHANGHAI and TAIPEI, May 5, 2014 /PRNewswire/ -- WuXi PharmaTech (NYSE: WX) and TaiMed Biologics today announced that the FDA has approved the first batch of the ibalizumab (TMB-355) drug substance and sterile drug product manufactured at WuXi's biologics facilities for ongoing treatment of patients...

2014-05-05 20:00 1253

bioCSL supports public health efforts in Laos with donation of more than 700,000 doses of seasonal influenza vaccine

-- Participation in innovative public-private collaboration helps improve vaccination infrastructure, expand patient reach in partner countries KING OF PRUSSIA, Pa., April 29, 2014 /PRNewswire/ -- bioCSL, formerly CSL Biotherapies, has announced the donation of more than 700,000 doses of its influe...

2014-04-29 01:23 2583

Thomson Reuters Study Shows Potential Malaria Vaccine on Horizon as Global Climate Change Threatens to Increase World Incidence Rate

- New analysis in support of World Malaria Day reveals key advances and challenges in malaria research PHILADELPHIA, April 25, 2014 /PRNewswire/ -- In recognition of World Malaria Day, the Intellectual Property & Science business of Thomson Reuters( http://ip-science.thomsonreuters.com ), the wor...

2014-04-25 15:46 1083

Sinovac Receives Notification of China Government Grant for EV71 Vaccine Project

BEIJING, April 24, 2014 /PRNewswire/ -- Sinovac Biotech Ltd. (NASDAQ: SVA), a leading China-based vaccine manufacturer, announced today that it has received notification that a RMB 60 million free government grant has been approved by China's Ministry of Finance, National Development and Reform Comm...

2014-04-24 18:00 1404

International SOS Sees Increase in Demand for Malaria Advice

-- Requests for advice from travellers, expatriates and overseas workers up 27% since 2010 -- 11% of all International SOS medical cases attributed to infectious illnesses including malaria and dengue fever BEIJING, April 21, 2014 /PRNewswire/ -- International SOS has seen a 27% rise in the ...

2014-04-21 14:38 1316

Lilly and Novast Announce Ground Breaking of State of the Art Manufacturing Facility Expansion in Nantong, China

Opens a new chapter in their Strategic Partnership NANTONG, China, March 5, 2014 /PRNewswire/ -- Lilly and Novast Laboratories Ltd. (Novast), today announced that they have commenced the expansion of manufacturing and development facility capacities in Nantong, Jiangsu, China. The expansion is a ...

2014-03-05 13:48 2298

Lung Cancer Stage Four 10 Years Cancer-Free Through Non-toxic Alternative Cancer Treatment

-- Recurrent lung cancer responds to Integrative Immunotherapy SCOTTSDALE, Ariz., Feb. 11, 2014 /PRNewswire/ -- Lung cancer is the most common cause of cancer-related death worldwide, with the highly malignant small cell lung cancer having the worst prognosis. In recent years the surge of immuno...

2014-02-11 23:07 1928

Sinovac Files Clinical Trial Application with CFDA for its Proprietary Vaccine against Avian Influenza A(H7N9) Virus

BEIJING, Jan. 29, 2014 /PRNewswire/ -- Sinovac Biotech Ltd. (Nasdaq:SVA), a leading provider of biopharmaceutical products in China, announced today that it has submitted a Clinical Trial Application(CTA) with the China Food and Drug Administration (CFDA) to commence human clinical trials for its va...

2014-01-29 20:07 1139

(RED), U2 and Bank of America Partner to Fight AIDS

-- Partnership will deliver more than $10 million to fight AIDS and launch with free download of new U2 song debuting during Super Bowl NEW YORK, Jan. 24, 2014 /PRNewswire/ -- (RED), rock group U2 and Bank of America today announced a partnership that will generate more than $10 million to fight AI...

2014-01-24 22:34 2217

Infinitus Promotes Healthy Life in Four Markets across Straits by Adopting Unique R&D System

HONG KONG, Dec. 30, 2013 /PRNewswire/ -- On 9 December, Academic Seminar for Hong Kong Traditional Chinese Medicine Research Centre (HKTCMRC) & Infinitus Scientific Advisory Board 2013 was held by Infinitus in Guangzhou. Principal Researcher of HKTCMRC Prof. Robert Ko and his research team from Hon...

2013-12-30 18:38 2576

Life Technologies' Food Pathogen Detection Methods Gains Approval by Australian Government

- Life Technologies' MicroSEQ(R) Real-Time PCR workflows approved as method for testing Australian export meat and meat products MELBOURNE, Australia, Dec. 16, 2013 /PRNewswire/ -- Life Technologies Corporation ( http://www.lifetech.com )(NASDAQ:LIFE) today announced that its MicroSEQ(R) Real-Tim...

2013-12-16 15:48 1494
1 ... 39404142434445